Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine
Clinical trial NCT05161871 · COMPLETED
Trial details
- NCT number
- NCT05161871
- Sponsor
- University of L'Aquila
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2023-01-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.